Cover Image

Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review

Saved in:

Bibliographic Details
Main Authors:	Duy C. Tran, MD (Author), Maria Karim, BA (Author), Kristen Lo Sicco, MD (Author), Nooshin Brinster, MD (Author), Emily C. Milam, MD (Author), Ian W. Tattersall, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lenvatinib-induced psoriasiform eruption and palmoplantar erythema in a patient with hepatocellular carcinoma
by: Rachel Sally, BA, et al.
Published: (2021)

A new eruption of bullous pemphigoid within psoriatic plaques following cyclosporine withdrawal
by: Katerina Svigos, BA, et al.
Published: (2021)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
by: Mara Leyendecker, BS, et al.
Published: (2021)

Psoriasiform eruption on the face and extremities associated with nivolumab therapy
by: Amit Om, MD, et al.
Published: (2018)

Clinical pearl: Punch biopsy technique for alopecias
by: Elizabeth J. Klein, BA, et al.
Published: (2022)

Histological analysis of psoriasiform eruption associated with myelin oligodendrocyte glycoprotein antibody-associated disease
by: Saori Itoi-Ochi, MD, PhD, et al.
Published: (2024)

Reversible hair loss in a patient with cicatricial alopecia: A case of regrowth associated with pioglitazone use
by: Maria Karim, BA, et al.
Published: (2022)

Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia: A Case Report
by: Christopher Bowman MD, et al.
Published: (2017)

Necrolytic acral erythema in a patient with sarcoidosis
by: Payal Shah, BS, et al.
Published: (2020)

Permanent chemotherapy-induced alopecia presenting with erosive pustular dermatosis-like retention hyperkeratosis
by: Avani Kolla, BPhil, et al.
Published: (2022)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
by: Daniel Gutierrez, MD, et al.
Published: (2022)

Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
by: Spencer McClure, MD, et al.
Published: (2023)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
by: Xueqin Huang, et al.
Published: (2023)

A hypopigmented and enlarging granulomatous eruption
by: Michelle Sikora, BS, et al.
Published: (2024)

Osimertinib-associated erythema dyschromicum perstans-like eruption: A case series
by: Christina S. Oh, BA, et al.
Published: (2023)

Disparities in Janus kinase inhibitor access for alopecia areata: a retrospective analysis
by: Elizabeth J. Klein, MD, et al.
Published: (2024)

Psoriasiform mycosis fungoides-cutaneous T-cell lymphoma in an African American
by: Austinn C. Miller, MD, et al.
Published: (2023)

Delayed granulomatous eruption of the nose associated with ruxolitinib
by: Margaret Brown, MD, et al.
Published: (2020)

A Case of Ixekizumab-induced Psoriasiform Eruption
by: Tomohiro Oiwa, et al.
Published: (2019)

Psoriasiform Drug Eruption Associated with Sodium Valproate
by: Gulen Gul Mert, et al.
Published: (2013)

Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series
by: Neda Shahriari, MD, et al.
Published: (2024)

Phosphoinositide 3-kinase: friend and foe in cardiovascular disease
by: Alessandra eGhigo, et al.
Published: (2015)

Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?
by: David Pesqué, et al.
Published: (2021)

Psoriasiform lichen planopilaris: Unusual variant or coincidence
by: Eingun James Song, MD, et al.
Published: (2021)

A case of psoriasiform drug eruption caused by temozolomide
by: Tokuko Oguro, et al.
Published: (2022)

Psoriasiform drug eruption provoked by oriental herbal decoction 'Hyeonggaeyeongyotang'
by: Osung K, et al.
Published: (2017)

Psoriasiform drug eruption provoked by oriental herbal decoction 'Hyeonggaeyeongyotang'
by: Osung Kwon, et al.
Published: (2017)

Delayed-onset vemurafenib-induced panniculitis
by: Stephen L. Vance, MD, MBA, et al.
Published: (2017)

NEURODEGENERATION CAUSED BY TRIMETHYLTIN VIA INHIBITION OF TROPOMYOSIN-RECEPTOR-KINASE B AND PHOSPHOINOSITIDE 3-KINASE/PROTEIN KINASE B SIGNALING CASCADE
by: Tran Phi Hoang Yen, et al.
Published: (2014)

Paradoxical psoriasiform dermatitis involving the nasal mucosa in the setting of infliximab for inflammatory bowel disease
by: Subin Jacob-Geor, et al.
Published: (2024)

Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling
by: Kayo Tanita, et al.
Published: (2015)

Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab
by: Mayu Sato, et al.
Published: (2024)

Psoriasiform Fixed-Drug Eruption to Ibuprofen: A Rare Variant of Fixed-Drug Eruption in a Child
by: Annie Raizada, et al.
Published: (2021)

Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
by: Ambika Nohria, BA, et al.
Published: (2021)

Acute pruritic eruption
by: Hannah Soltani, BA, et al.
Published: (2024)

Eruption of hemorrhagic bullae and vesicles
by: Sabah Osmani, BA, et al.
Published: (2022)

The Inhibition of Phosphoinositide-3 Kinases Induce Resolution of Inflammation in a Gout Model
by: Izabela Galvão, et al.
Published: (2019)

Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome
by: Surya K. De, et al.
Published: (2024)

Activated phosphoinositide 3‐kinase delta syndrome: Pathogenesis, clinical manifestations, and treatment
by: Ke Zhu, et al.
Published: (2024)

Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence
by: Marketa Bloomfield, et al.
Published: (2021)